These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19487492)

  • 1. Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.
    Fukudo M; Yano I; Shinsako K; Katsura T; Takada Y; Uemoto S; Inui K
    J Clin Pharmacol; 2009 Jul; 49(7):789-97. PubMed ID: 19487492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients.
    Taber DJ; Dupuis RE; Fann AL; Andreoni KA; Gerber DA; Fair JH; Johnson MW; Shrestha R
    Liver Transpl; 2002 Mar; 8(3):219-23. PubMed ID: 11910566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
    Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
    Goto M; Masuda S; Kiuchi T; Ogura Y; Oike F; Tanaka K; Uemoto S; Inui K
    J Pharmacol Exp Ther; 2008 May; 325(2):610-6. PubMed ID: 18252812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B; Duvoux C; Costentin CE; Barrault C; Ghaleh B; Salvat A; Jouault H; Astier A; Tod M; Hulin A
    Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian and time-dependent variability in tacrolimus pharmacokinetics.
    Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2007 Apr; 21(2):191-7. PubMed ID: 17391292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily prolonged-release tacrolimus in de novo liver transplantation: a single center cohort study.
    Marubashi S; Wada H; Kobayashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Hepatogastroenterology; 2012 Jun; 59(116):1184-8. PubMed ID: 22172333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buccal vs. nasogastric tube administration of tacrolimus after pediatric liver transplantation.
    Goorhuis JF; Scheenstra R; Peeters PM; Albers MJ
    Pediatr Transplant; 2006 Feb; 10(1):74-7. PubMed ID: 16499591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.
    Charco R; Rimola A; García-Valdecasas JC; Fuster J; Fondevila C; Navasa M; Julian M; Forta V; Brunet M
    Transplant Proc; 2005 Nov; 37(9):3930-1. PubMed ID: 16386588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tacrolimus bioavailability is increased after right split liver transplantation.
    Wilberg J; Küpper B; Thrum K; Bärthel E; Koch A; Settmacher U; Kornberg A
    Transplant Proc; 2007 Dec; 39(10):3237-8. PubMed ID: 18089362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.